Measles, rubella, and mumps titers post chemotherapy plus autologous stem cell transplant in multiple myeloma patients-Reference-Cited by-同舟云学术

Measles, rubella, and mumps titers post chemotherapy plus autologous stem cell transplant in multiple myeloma patients

Published:2021-12 Issue:2 Volume:97 Page:
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Arribas Mariano¹^ORCID,Ahmann Greg J.¹,Buckner Petty Skye²,Braggio Esteban¹,Theel Elitza S.³,Fonseca Rafael¹

Affiliation:

1. Department of Hematology/Oncology Mayo Clinic Scottsdale Arizona USA

2. Division of Health Sciences Research Mayo Clinic Scottsdale Arizona USA

3. Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology Mayo Clinic Rochester Minnesota USA

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26421

Reference6 articles.

1. Centers for Disease Control and Prevention.Prevention of measles rubella congenital rubella syndrome and mumps 2013. Accessed July 20 2020.https://www.cdc.gov/mmwr/preview/mmwrhtml/rr6204a1.htm

2. Management of Newly Diagnosed Symptomatic Multiple Myeloma: Updated Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Guidelines 2013

3. Vaccination of hematopoietic cell transplant recipients

4. Safety of live-attenuated measles-mumps-rubella and herpes zoster vaccination in multiple myeloma patients on maintenance lenalidomide or bortezomib after autologous hematopoietic cell transplantation

5. Performance Characteristics of Four High-Throughput Immunoassays for Detection of IgG Antibodies against SARS-CoV-2

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunity Against Measles in Korean Autologous Hematopoietic Stem Cell Transplant Recipients;Journal of Korean Medical Science;2024

2. Real-world challenges in eligibility for MMR vaccination two years after autologous and allogeneic HSCT;Vaccine;2023-09